GEARING UP FOR WWJ 950'S THAW RADIOTHON: DONATE ONLINE HERE  

Alta Partners

Esperion Gets $33M To Continue Work On Cholesterol BusterThe Ann Arbor biotech firm Esperion Therapeutics Inc. announced that it has completed a $33 million preferred stock financing led by new investor Longitude Capital.

More From CBS Detroit

Daily J
Valenti and Foster

Watch & Listen